C.‐H. Bergh
Impact in
-
- Heart Failure Treatment and Management
- Viral Infections and Immunology Research
-
- Pain Management and Treatment
Papers in
-
- Heart Failure Treatment and Management 4
-
- Growth Hormone and Insulin-like Growth Factors 2
- Co-authors
- Finn Waagstein (9 shared papers)Åke C. Hjalmarson (8 shared papers)Kenneth Caidahl (3 shared papers)I Wallentin (1 shared paper)Johan Hoebeke (3 shared papers)L.-X. Fu (3 shared papers)Ylva Magnusson (2 shared papers)Jan‐Åke Liljeqvist (1 shared paper)
In The Last Decade
C.‐H. Bergh
20 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 62
- Cardiology and Cardiovascular Medicine 643
- Anesthesiology and Pain Medicine 162
- Pulmonary and Respiratory Medicine 237
- Endocrinology, Diabetes and Metabolism 112
- Behavioral Neuroscience 14
Countries citing papers authored by C.‐H. Bergh
This map shows the geographic impact of C.‐H. Bergh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.‐H. Bergh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.‐H. Bergh more than expected).
Fields of papers citing papers by C.‐H. Bergh
This network shows the impact of papers produced by C.‐H. Bergh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.‐H. Bergh. The network helps show where C.‐H. Bergh may publish in the future.
Co-authors
The 25 scholars most cited alongside C.‐H. Bergh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 369 | |
| 2 | 1993 | 231 | |
| 3 | 1993 | 179 | |
| 4 | 1993 | 164 | |
| 5 | 2009 | 158 | |
| 6 | Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. | 1994 | 102 |
| 7 | 2001 | 98 | |
| 8 | 1997 | 60 | |
| 9 | 2003 | 29 | |
| 10 | 1988 | 19 | |
| 11 | 1991 | 18 | |
| 12 | 1988 | 17 | |
| 13 | 1983 | 16 | |
| 14 | Prognosis of alternative therapies in patients with heart failure not accepted for heart transplantation. | 1996 | 13 |
| 15 | 1985 | 12 | |
| 16 | 1999 | 11 | |
| 17 | 1992 | 10 | |
| 18 | 1998 | 2 | |
| 19 | 1998 | 1 | |
| 20 | 2006 | 1 |
About C.‐H. Bergh
C.‐H. Bergh is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Anesthesiology and Pain Medicine, Hematology and Surgery, having authored 20 papers that have together received 1.5k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (4 papers), Transplantation: Methods and Outcomes (4 papers), Receptor Mechanisms and Signaling (2 papers), Pulmonary Hypertension Research and Treatments (2 papers), Platelet Disorders and Treatments (2 papers), Growth Hormone and Insulin-like Growth Factors (2 papers), Pain Management and Treatment (2 papers) and Cardiac Ischemia and Reperfusion (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (643 citations), Anesthesiology and Pain Medicine (162 citations), Pulmonary and Respiratory Medicine (237 citations), Endocrinology, Diabetes and Metabolism (112 citations) and Behavioral Neuroscience (14 citations). C.‐H. Bergh has collaborated with scholars based in Sweden, France and Norway. Frequent co-authors include Finn Waagstein, Åke C. Hjalmarson, Kenneth Caidahl, I Wallentin, Johan Hoebeke, L.-X. Fu, Ylva Magnusson, Jan‐Åke Liljeqvist, Bert Andersson and L.-E. Augustinsson. Their work appears in journals such as Journal of Clinical Investigation, European Journal of Clinical Investigation, European Heart Journal, European Respiratory Journal and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.